MELROSE GASTROENTEROLOGY LIMITED

🌳Matureactive

SC524745 · ltd · incorporated 2016-01-20

Investment thesis

Well-run mature business — low negotiation leverage; premium likely.

Why interesting: Textbook target; clean filings, stable trading.

Why risky: No pressure on seller; any deal likely at full price.

Opportunity decay

hardening · 12-months

Already tight — no obvious softening catalysts on the horizon.

· Thesis: well-run, low negotiation leverage

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Jan 2025

Net worth

£5.0k

book net assets

Opportunity

79/100

Strong

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Specialist medical practice activities

Sector: Human health & social work

Investor take

Pursue

Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 79/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

2 officers (2 active, 2 linked, 2 with DOB)

Ownership & PSC

1 active PSC(s) of 1 total, 1 with control declared

Director network

Network not yet resolved

Filing history

20 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

79/100Strong

PassWatchWorth a lookStrongExceptional

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)

Positive net assets

Net assets £4,955

Net assets shrinking

Down £10,246 YoY

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

£5k

↓ 67% YoY

Current Assets

£17k

↓ 45% YoY

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)

Metric	2025-01-31	2024-01-31
Total assets	£5.0k	£15.2k
Current assets	£16.9k	£30.6k
Net assets	£5.0k	£15.2k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filings

Last 180 days

filing

• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (13 events)Click to expand

2025-10-22
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2024-10-30
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2023-10-24
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2022-10-03
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2021-08-16
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2020-10-28
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2019-10-30
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2018-10-29
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2017-10-13
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2016-01-20
🏢
Company incorporated
As MELROSE GASTROENTEROLOGY LIMITED
2016-01-20
➕
FLETCHER, Catharine appointed
director
2016-01-20
➕
FLETCHER, Jonathan, Dr appointed
director
2016-01-20
📄
incorporation-company
incorporation · NEWINC

Owner dependency

79/100

High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS

+Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
+Senior director age: Director aged approximately 63 — approaching natural succession window.
+Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
+No director turnover: Company is 10 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

61/100

Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS

primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner

Name	Shares	Voting rights	Nature of control	Notified
Dr Jonathan Fletcher Individual · British · DOB 06/1966 · age 60	50–75%	—	50-75% shares	06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · TD postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
LASER VISION SCOTLAND LTD→ SC448890 · est 2013	£11.07M £7.97M–£14.18M	£13.54M	—	7500	13y	84	58y
AKAM CARE LIMITED→ SC379940 · est 2010	—	—	£249.4k	—	16y	82	62y
SCOTIA CHIROPRACTIC LIMITED→ SC138934 · est 1992	—	—	£105.9k	—	33y	82	64y
BORDERS INDEPENDENT ADVOCACY SERVICE→ SC281185 · est 2005 · no financials extracted	—	—	—	—	21y	81	77y
CENTRAL BORDERS CITIZENS ADVICE BUREAU→ SC217973 · est 2001	—	—	—	7	25y	81	79y
STREETS AHEAD (BORDERS)→ SC105923 · est 1987	—	—	—	142	38y	81	77y
FLEXIBLE RESPITE LTD→ SC504233 · est 2015	—	—	—	1800	11y	79	63y
FOSTER CARE CONNECT LTD.→ SC261956 · est 2004	—	—	£610.4k	—	22y	79	59y
FTS CARE LTD→ SC355267 · est 2009	—	—	—	3800	17y	79	62y
PRYCE & CO LIMITED→ SC157925 · est 1995	—	—	£480.1k	—	31y	79	79y
BERWICK CARE HOMES LIMITED→ 03092064 · est 1995	—	—	£1.37M	—	30y	78	61y
CROWNSMITH LIMITED→ 07114526 · est 2009	—	—	—	12	16y	78	66y

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2016-01-20

Jurisdictionscotland

Primary SIC86220 — Specialist medical practice activities

Registered office

Abbey Place

Cloisters Road

Melrose

TD6 9LQ

United Kingdom

Filing status

Accounts

Next due: 2026-10-31

Last made up to: 2025-01-31

Confirmation statement

Next due: 2027-01-28

Last: 2026-01-14

Officers (2 active · 0 resigned)

FLETCHER, Catharine→

director · ~63y · appointed 2016-01-20

View their other companies + combined net worth →

Active

FLETCHER, Jonathan, Dr→

director · ~60y · appointed 2016-01-20

View their other companies + combined net worth →

Active

Click a director name to see their full track record across all companies.